Manipur HC: State Establishments Must Record Transgender Person’s New Name & Gender in Documents  ||  Delhi HC: Failure to Frame Counter Claim Despite Pleadings is Patently Illegal  ||  Mumbai Commission Holds Reliance Retail Liable for Defective AC Replacement Failure  ||  SC Orders ASI to Supervise Repair of Mehrauli’s Ancient Dargahs  ||  SC Reprimands Bihar IPS Officer for Affidavit Supporting Murder Convict  ||  SC Rejects Review Plea on WB SSC Jobs, Upholds Quashing of 25k Appointments  ||  SC Rejects Review Plea on WB SSC Jobs, Upholds Quashing of 25k Appointments  ||  Supreme Court Orders Haridwar Collector Inquiry into Maa Chandi Devi Trust  ||  SC Recommends Statutory Appeal Against DJ’s Compensation Orders  ||  SC Dismisses Petition Challenging 2024 Maharashtra Assembly Elections Over Bogus Voting    

Novartis Books Indian Patent for Skin Cancer Drug ‘Tafinlar’ - (21 Sep 2016)

Novartis AG has secured an Indian patent for its skin cancer drug Tafinlar, used in treatment of metastatic melanoma- the most serious and life-threatening type of skin cancer that is associated with low survival rates.

Tags : NOVARTIS   PATENT   TAFINLAR  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved